Galectin-3 and cardiac resynchronization therapy

• 收藏
• 分享

专利权人:

Pieter Muntendam

发明人:

Pieter Muntendam

申请号：

US12868612

公开号：

US08672857B2

申请日:

2010.08.25

申请国别(地区):

US

年份:

2014

代理人:

摘要：

The present invention relates to materials and methods for monitoring and predicting a heart failure patients physiological response to cardiac resynchronization therapy. More specifically, the present invention relates to the endogenous protein galectin-3 and its use in monitoring progression of disease in a patient undergoing cardiac resynchronization therapy, and as a predictor of response to cardiac resynchronization therapy.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/